Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Dynavax Technologies Corp DVAX

Healthcare Drug Manufacturers - Specialty & Generic
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Ep...


NDAQ:DVAX - Post by User

Dynavax Technologies Corp
Bullboard Posts
Next >>
User Avatar Image
(3)
•••
  • wmcveyX
Post by wmcveyon Aug 14, 2020 5:25am
436 Views
Post# 31406981

$3.5 mil grant from bill and milinda gates foundation

$3.5 mil grant from bill and milinda gates foundationhttps://www.globenewswire.com/news-release/2020/08/13/2077857/0/en/Dynavax-Announces-Grant-to-Scale-up-CpG-1018-Adjuvant-Capacity-to-Support-the-Global-COVID-19-Response.html

This news alongside recent reports in a rebound of the hep vaccine uptake.  Promising for this stock to continue to rise.
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities